Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 21 entries
Sorted by: Best Match Show Resources per page
Corrigendum to "Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia)" [Eur J Canc. vol. 139 November (2020) Pages 149-168].

European journal of cancer (Oxford, England : 1990)

Ferrandina G, Aristei C, Biondetti PR, Cananzi FCM, Casali P, Ciccarone F, Colombo N, Comandone A, Corvo' R, De Iaco P, Dei Tos AP, Donato V, Fiore M, Franchi, Gadducci A, Gronchi A, Guerriero S, Infante A, Odicino F, Pirronti T, Quagliuolo V, Sanfilippo R, Testa AC, Zannoni GF, Scambia G, Lorusso D.
PMID: 33353792
Eur J Cancer. 2021 Feb;144:397-398. doi: 10.1016/j.ejca.2020.11.001. Epub 2020 Dec 22.

No abstract available.

Cite
Ferrandina G, Aristei C, Biondetti PR, et al. Corrigendum to "Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia)" [Eur J Canc. vol. 139 November (2020) Pages 149-168]. Eur J Cancer. 2020;144:397-398doi: 10.1016/j.ejca.2020.11.001.
Ferrandina, G., Aristei, C., Biondetti, P. R., Cananzi, F. C. M., Casali, P., Ciccarone, F., Colombo, N., Comandone, A., Corvo', R., De Iaco, P., Dei Tos, A. P., Donato, V., Fiore, M., Franchi, Gadducci, A., Gronchi, A., Guerriero, S., Infante, A., Odicino, F., Pirronti, T., Quagliuolo, V., Sanfilippo, R., Testa, A. C., Zannoni, G. F., Scambia, G., & Lorusso, D. (2021). Corrigendum to "Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia)" [Eur J Canc. vol. 139 November (2020) Pages 149-168]. European journal of cancer (Oxford, England : 1990), 144397-398. https://doi.org/10.1016/j.ejca.2020.11.001
Ferrandina, Gabriella, et al. "Corrigendum to "Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia)" [Eur J Canc. vol. 139 November (2020) Pages 149-168]." European journal of cancer (Oxford, England : 1990) vol. 144 (2021): 397-398. doi: https://doi.org/10.1016/j.ejca.2020.11.001
Ferrandina G, Aristei C, Biondetti PR, Cananzi FCM, Casali P, Ciccarone F, Colombo N, Comandone A, Corvo' R, De Iaco P, Dei Tos AP, Donato V, Fiore M, Franchi, Gadducci A, Gronchi A, Guerriero S, Infante A, Odicino F, Pirronti T, Quagliuolo V, Sanfilippo R, Testa AC, Zannoni GF, Scambia G, Lorusso D. Corrigendum to "Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia)" [Eur J Canc. vol. 139 November (2020) Pages 149-168]. Eur J Cancer. 2021 Feb;144:397-398. doi: 10.1016/j.ejca.2020.11.001. Epub 2020 Dec 22. PMID: 33353792.
Copy Download .nbib Format: NLM
Another look at dietary polyphenols: challenges in cancer prevention and treatment.

Current medicinal chemistry

Arrigoni R, Ballini A, Santacroce L, Cantore S, Inchingolo A, Inchingolo F, Di Domenico M, Quagliuolo L, Boccellino M.
PMID: 34375181
Curr Med Chem. 2021 Aug 10; doi: 10.2174/0929867328666210810154732. Epub 2021 Aug 10.

Cancer is a pathology that impacts in a profound manner people all over the world. The election strategy against cancer often uses chemotherapy and radiotherapy, which more often than not can present many side effects and not always reliable...

Cite
Arrigoni R, Ballini A, Santacroce L, et al. Another look at dietary polyphenols: challenges in cancer prevention and treatment. Curr Med Chem. 2021;doi: 10.2174/0929867328666210810154732.
Arrigoni, R., Ballini, A., Santacroce, L., Cantore, S., Inchingolo, A., Inchingolo, F., Di Domenico, M., Quagliuolo, L., & Boccellino, M. (2021). Another look at dietary polyphenols: challenges in cancer prevention and treatment. Current medicinal chemistry, . https://doi.org/10.2174/0929867328666210810154732
Arrigoni, Roberto, et al. "Another look at dietary polyphenols: challenges in cancer prevention and treatment." Current medicinal chemistry vol. (2021). doi: https://doi.org/10.2174/0929867328666210810154732
Arrigoni R, Ballini A, Santacroce L, Cantore S, Inchingolo A, Inchingolo F, Di Domenico M, Quagliuolo L, Boccellino M. Another look at dietary polyphenols: challenges in cancer prevention and treatment. Curr Med Chem. 2021 Aug 10; doi: 10.2174/0929867328666210810154732. Epub 2021 Aug 10. PMID: 34375181.
Copy Download .nbib Format: NLM
Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial.

Molecular cancer therapeutics

Martin-Broto J, Lopez-Alvarez M, Moura DS, Ramos R, Collini P, Romagosa C, Bagué S, Renne SL, Barisella M, Velasco V, Coindre JM, Lopez-Lopez D, Dopazo J, Gambarotti M, Braglia L, Merlo DF, Palmerini E, Stacchiotti S, Quagliuolo VL, Lopez-Pousa A, Grignani G, Blay JY, Brunello A, Gutierrez A, Valverde C, Hindi N, Dei Tos AP, Picci P, Casali PG, Gronchi A.
PMID: 34552008
Mol Cancer Ther. 2021 Dec;20(12):2539-2552. doi: 10.1158/1535-7163.MCT-21-0315. Epub 2021 Sep 22.

MRP-1 is implicated in multidrug resistance and was described as prognostic in high-risk patients with soft-tissue sarcoma (STS) in a previous study. The current research aimed to validate MRP-1 prognostic/predictive value in localized sarcomas treated with anthracyclines plus ifosfamide...

Cite
Martin-Broto J, Lopez-Alvarez M, Moura DS, et al. Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial. Mol Cancer Ther. 2021;20(12):2539-2552doi: 10.1158/1535-7163.MCT-21-0315.
Martin-Broto, J., Lopez-Alvarez, M., Moura, D. S., Ramos, R., Collini, P., Romagosa, C., Bagué, S., Renne, S. L., Barisella, M., Velasco, V., Coindre, J. M., Lopez-Lopez, D., Dopazo, J., Gambarotti, M., Braglia, L., Merlo, D. F., Palmerini, E., Stacchiotti, S., Quagliuolo, V. L., Lopez-Pousa, A., Grignani, G., Blay, J. Y., Brunello, A., Gutierrez, A., Valverde, C., Hindi, N., Dei Tos, A. P., Picci, P., Casali, P. G., & Gronchi, A. (2021). Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial. Molecular cancer therapeutics, 20(12), 2539-2552. https://doi.org/10.1158/1535-7163.MCT-21-0315
Martin-Broto, Javier, et al. "Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial." Molecular cancer therapeutics vol. 20,12 (2021): 2539-2552. doi: https://doi.org/10.1158/1535-7163.MCT-21-0315
Martin-Broto J, Lopez-Alvarez M, Moura DS, Ramos R, Collini P, Romagosa C, Bagué S, Renne SL, Barisella M, Velasco V, Coindre JM, Lopez-Lopez D, Dopazo J, Gambarotti M, Braglia L, Merlo DF, Palmerini E, Stacchiotti S, Quagliuolo VL, Lopez-Pousa A, Grignani G, Blay JY, Brunello A, Gutierrez A, Valverde C, Hindi N, Dei Tos AP, Picci P, Casali PG, Gronchi A. Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial. Mol Cancer Ther. 2021 Dec;20(12):2539-2552. doi: 10.1158/1535-7163.MCT-21-0315. Epub 2021 Sep 22. PMID: 34552008.
Copy Download .nbib Format: NLM
Oral Microbiota and Immune System Crosstalk: A Translational Research.

Biology

Ballini A, Dipalma G, Isacco CG, Boccellino M, Di Domenico M, Santacroce L, Nguyễn KCD, Scacco S, Calvani M, Boddi A, Corcioli F, Quagliuolo L, Cantore S, Martelli FS, Inchingolo F.
PMID: 32560235
Biology (Basel). 2020 Jun 16;9(6). doi: 10.3390/biology9060131.

BACKGROUND: Oral pathogens may exert the ability to trigger differently the activation of local macrophage immune responses, for instance METHODS: In healthy individuals vs. periodontal disease patients' blood samples, the differentiation process from monocyte to M1 and M2 was...

Cite
Ballini A, Dipalma G, Isacco CG, et al. Oral Microbiota and Immune System Crosstalk: A Translational Research. Biology (Basel). 2020;9(6)doi: 10.3390/biology9060131.
Ballini, A., Dipalma, G., Isacco, C. G., Boccellino, M., Di Domenico, M., Santacroce, L., Nguyễn, K. C. D., Scacco, S., Calvani, M., Boddi, A., Corcioli, F., Quagliuolo, L., Cantore, S., Martelli, F. S., & Inchingolo, F. (2020). Oral Microbiota and Immune System Crosstalk: A Translational Research. Biology, 9(6), . https://doi.org/10.3390/biology9060131
Ballini, Andrea, et al. "Oral Microbiota and Immune System Crosstalk: A Translational Research." Biology vol. 9,6 (2020). doi: https://doi.org/10.3390/biology9060131
Ballini A, Dipalma G, Isacco CG, Boccellino M, Di Domenico M, Santacroce L, Nguyễn KCD, Scacco S, Calvani M, Boddi A, Corcioli F, Quagliuolo L, Cantore S, Martelli FS, Inchingolo F. Oral Microbiota and Immune System Crosstalk: A Translational Research. Biology (Basel). 2020 Jun 16;9(6). doi: 10.3390/biology9060131. PMID: 32560235; PMCID: PMC7344575.
Copy Download .nbib Format: NLM
The Role of Oxidative Stress and Hormones in Controlling Obesity.

Frontiers in endocrinology

Di Domenico M, Pinto F, Quagliuolo L, Contaldo M, Settembre G, Romano A, Coppola M, Ferati K, Bexheti-Ferati A, Sciarra A, Nicoletti GF, Ferraro GA, Boccellino M.
PMID: 31456748
Front Endocrinol (Lausanne). 2019 Aug 13;10:540. doi: 10.3389/fendo.2019.00540. eCollection 2019.

The accumulation of adipose tissue in the body occurs because the energy introduced with food and drink exceeds that expense, but to understand why this imbalance is established and why it is maintained over time, it is important to...

Cite
Di Domenico M, Pinto F, Quagliuolo L, et al. The Role of Oxidative Stress and Hormones in Controlling Obesity. Front Endocrinol (Lausanne). 2019;10:540doi: 10.3389/fendo.2019.00540.
Di Domenico, M., Pinto, F., Quagliuolo, L., Contaldo, M., Settembre, G., Romano, A., Coppola, M., Ferati, K., Bexheti-Ferati, A., Sciarra, A., Nicoletti, G. F., Ferraro, G. A., & Boccellino, M. (2019). The Role of Oxidative Stress and Hormones in Controlling Obesity. Frontiers in endocrinology, 10540. https://doi.org/10.3389/fendo.2019.00540
Di Domenico, Marina, et al. "The Role of Oxidative Stress and Hormones in Controlling Obesity." Frontiers in endocrinology vol. 10 (2019): 540. doi: https://doi.org/10.3389/fendo.2019.00540
Di Domenico M, Pinto F, Quagliuolo L, Contaldo M, Settembre G, Romano A, Coppola M, Ferati K, Bexheti-Ferati A, Sciarra A, Nicoletti GF, Ferraro GA, Boccellino M. The Role of Oxidative Stress and Hormones in Controlling Obesity. Front Endocrinol (Lausanne). 2019 Aug 13;10:540. doi: 10.3389/fendo.2019.00540. eCollection 2019. PMID: 31456748; PMCID: PMC6701166.
Copy Download .nbib Format: NLM
Rebalancing the Oral Microbiota as an Efficient Tool in Endocrine, Metabolic and Immune Disorders.

Endocrine, metabolic & immune disorders drug targets

Isacco CG, Ballini A, De Vito D, Nguyen KCD, Cantore S, Bottalico L, Quagliuolo L, Boccellino M, Di Domenico M, Santacroce L, Arrigoni R, Dipalma G, Inchingolo F.
PMID: 32727337
Endocr Metab Immune Disord Drug Targets. 2021;21(5):777-784. doi: 10.2174/1871530320666200729142504.

The current treatment and prevention procedures of oral disorders follow a very targeted approach considering mouth and its structures as a system that is completely independent, than the rest of the body. The main therapeutic approach is to keep...

Cite
Isacco CG, Ballini A, De Vito D, et al. Rebalancing the Oral Microbiota as an Efficient Tool in Endocrine, Metabolic and Immune Disorders. Endocr Metab Immune Disord Drug Targets. 2021;21(5):777-784doi: 10.2174/1871530320666200729142504.
Isacco, C. G., Ballini, A., De Vito, D., Nguyen, K. C. D., Cantore, S., Bottalico, L., Quagliuolo, L., Boccellino, M., Di Domenico, M., Santacroce, L., Arrigoni, R., Dipalma, G., & Inchingolo, F. (2021). Rebalancing the Oral Microbiota as an Efficient Tool in Endocrine, Metabolic and Immune Disorders. Endocrine, metabolic & immune disorders drug targets, 21(5), 777-784. https://doi.org/10.2174/1871530320666200729142504
Isacco, Ciro Gargiulo, et al. "Rebalancing the Oral Microbiota as an Efficient Tool in Endocrine, Metabolic and Immune Disorders." Endocrine, metabolic & immune disorders drug targets vol. 21,5 (2021): 777-784. doi: https://doi.org/10.2174/1871530320666200729142504
Isacco CG, Ballini A, De Vito D, Nguyen KCD, Cantore S, Bottalico L, Quagliuolo L, Boccellino M, Di Domenico M, Santacroce L, Arrigoni R, Dipalma G, Inchingolo F. Rebalancing the Oral Microbiota as an Efficient Tool in Endocrine, Metabolic and Immune Disorders. Endocr Metab Immune Disord Drug Targets. 2021;21(5):777-784. doi: 10.2174/1871530320666200729142504. PMID: 32727337.
Copy Download .nbib Format: NLM
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.

Cancer

Pasquali S, Palmerini E, Quagliuolo V, Martin-Broto J, Lopez-Pousa A, Grignani G, Brunello A, Blay JY, Tendero O, Diaz-Beveridge R, Ferraresi V, Lugowska I, Infante G, Braglia L, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Bianchi G, Marrari A, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Miceli R, Casali PG, Gronchi A.
PMID: 34643947
Cancer. 2022 Jan 01;128(1):85-93. doi: 10.1002/cncr.33895. Epub 2021 Oct 13.

BACKGROUND: The value of neoadjuvant chemotherapy in soft tissue sarcoma (STS) is not completely understood. This study investigated the benefit of neoadjuvant chemotherapy according to prognostic stratification based on the Sarculator nomogram for STS.METHODS: This study analyzed data from...

Cite
Pasquali S, Palmerini E, Quagliuolo V, et al. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. Cancer. 2021;128(1):85-93doi: 10.1002/cncr.33895.
Pasquali, S., Palmerini, E., Quagliuolo, V., Martin-Broto, J., Lopez-Pousa, A., Grignani, G., Brunello, A., Blay, J. Y., Tendero, O., Diaz-Beveridge, R., Ferraresi, V., Lugowska, I., Infante, G., Braglia, L., Merlo, D. F., Fontana, V., Marchesi, E., Donati, D. M., Palassini, E., Bianchi, G., Marrari, A., Morosi, C., Stacchiotti, S., Bagué, S., Coindre, J. M., Dei Tos, A. P., Picci, P., Bruzzi, P., Miceli, R., Casali, P. G., & Gronchi, A. (2022). Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. Cancer, 128(1), 85-93. https://doi.org/10.1002/cncr.33895
Pasquali, Sandro, et al. "Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial." Cancer vol. 128,1 (2022): 85-93. doi: https://doi.org/10.1002/cncr.33895
Pasquali S, Palmerini E, Quagliuolo V, Martin-Broto J, Lopez-Pousa A, Grignani G, Brunello A, Blay JY, Tendero O, Diaz-Beveridge R, Ferraresi V, Lugowska I, Infante G, Braglia L, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Bianchi G, Marrari A, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Miceli R, Casali PG, Gronchi A. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. Cancer. 2022 Jan 01;128(1):85-93. doi: 10.1002/cncr.33895. Epub 2021 Oct 13. PMID: 34643947.
Copy Download .nbib Format: NLM
Snapshots Quiz.

The British journal of surgery

Zulian D, Samà L, Quagliuolo V.
PMID: 34426834
Br J Surg. 2021 Dec 01;108(12):1529. doi: 10.1093/bjs/znab262.

No abstract available.

Cite
Zulian D, Samà L, Quagliuolo V. Snapshots Quiz. Br J Surg. 2021;108(12):1529doi: 10.1093/bjs/znab262.
Zulian, D., Samà, L., & Quagliuolo, V. (2021). Snapshots Quiz. The British journal of surgery, 108(12), 1529. https://doi.org/10.1093/bjs/znab262
Zulian, D, et al. "Snapshots Quiz." The British journal of surgery vol. 108,12 (2021): 1529. doi: https://doi.org/10.1093/bjs/znab262
Zulian D, Samà L, Quagliuolo V. Snapshots Quiz. Br J Surg. 2021 Dec 01;108(12):1529. doi: 10.1093/bjs/znab262. PMID: 34426834.
Copy Download .nbib Format: NLM
H9c2 Cardiomyocytes under Hypoxic Stress: Biological Effects Mediated by Sentinel Downstream Targets.

Oxidative medicine and cellular longevity

Boccellino M, Galasso G, Ambrosio P, Stiuso P, Lama S, Di Zazzo E, Schiavon S, Vecchio D, D'ambrosio L, Quagliuolo L, Feola A, Frati G, Di Domenico M.
PMID: 34630851
Oxid Med Cell Longev. 2021 Sep 30;2021:6874146. doi: 10.1155/2021/6874146. eCollection 2021.

The association between diabetes and cardiovascular diseases is well known. Related diabetes macro- and microangiopathies frequently induce hypoxia and consequently energy failure to satisfy the jeopardized myocardium basal needs. Additionally, it is widely accepted that diabetes impairs endothelial nitric...

Cite
Boccellino M, Galasso G, Ambrosio P, et al. H9c2 Cardiomyocytes under Hypoxic Stress: Biological Effects Mediated by Sentinel Downstream Targets. Oxid Med Cell Longev. 2021;2021:6874146doi: 10.1155/2021/6874146.
Boccellino, M., Galasso, G., Ambrosio, P., Stiuso, P., Lama, S., Di Zazzo, E., Schiavon, S., Vecchio, D., D'ambrosio, L., Quagliuolo, L., Feola, A., Frati, G., & Di Domenico, M. (2021). H9c2 Cardiomyocytes under Hypoxic Stress: Biological Effects Mediated by Sentinel Downstream Targets. Oxidative medicine and cellular longevity, 20216874146. https://doi.org/10.1155/2021/6874146
Boccellino, Mariarosaria, et al. "H9c2 Cardiomyocytes under Hypoxic Stress: Biological Effects Mediated by Sentinel Downstream Targets." Oxidative medicine and cellular longevity vol. 2021 (2021): 6874146. doi: https://doi.org/10.1155/2021/6874146
Boccellino M, Galasso G, Ambrosio P, Stiuso P, Lama S, Di Zazzo E, Schiavon S, Vecchio D, D'ambrosio L, Quagliuolo L, Feola A, Frati G, Di Domenico M. H9c2 Cardiomyocytes under Hypoxic Stress: Biological Effects Mediated by Sentinel Downstream Targets. Oxid Med Cell Longev. 2021 Sep 30;2021:6874146. doi: 10.1155/2021/6874146. eCollection 2021. PMID: 34630851; PMCID: PMC8497098.
Copy Download .nbib Format: NLM
It was hard enough: the spectre of COVID-19 on the management of sarcoma patients.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Marrari A, Gennaro N, Cariboni U, Quagliuolo VL, D'Orazio F, Cananzi F, Santoro A, Bertuzzi AF.
PMID: 33990096
Eur J Cancer Prev. 2021 May 07; doi: 10.1097/CEJ.0000000000000692. Epub 2021 May 07.

No abstract available.

Cite
Marrari A, Gennaro N, Cariboni U, et al. It was hard enough: the spectre of COVID-19 on the management of sarcoma patients. Eur J Cancer Prev. 2021;doi: 10.1097/CEJ.0000000000000692.
Marrari, A., Gennaro, N., Cariboni, U., Quagliuolo, V. L., D'Orazio, F., Cananzi, F., Santoro, A., & Bertuzzi, A. F. (2021). It was hard enough: the spectre of COVID-19 on the management of sarcoma patients. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), . https://doi.org/10.1097/CEJ.0000000000000692
Marrari, Andrea, et al. "It was hard enough: the spectre of COVID-19 on the management of sarcoma patients." European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) vol. (2021). doi: https://doi.org/10.1097/CEJ.0000000000000692
Marrari A, Gennaro N, Cariboni U, Quagliuolo VL, D'Orazio F, Cananzi F, Santoro A, Bertuzzi AF. It was hard enough: the spectre of COVID-19 on the management of sarcoma patients. Eur J Cancer Prev. 2021 May 07; doi: 10.1097/CEJ.0000000000000692. Epub 2021 May 07. PMID: 33990096.
Copy Download .nbib Format: NLM
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.

Cancer

Pasquali S, Palmerini E, Quagliuolo V, Martin-Broto J, Lopez-Pousa A, Grignani G, Brunello A, Blay JY, Tendero O, Diaz-Beveridge R, Ferraresi V, Lugowska I, Infante G, Braglia L, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Bianchi G, Marrari A, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Miceli R, Casali PG, Gronchi A.
PMID: 34643947
Cancer. 2022 Jan 01;128(1):85-93. doi: 10.1002/cncr.33895. Epub 2021 Oct 13.

BACKGROUND: The value of neoadjuvant chemotherapy in soft tissue sarcoma (STS) is not completely understood. This study investigated the benefit of neoadjuvant chemotherapy according to prognostic stratification based on the Sarculator nomogram for STS.METHODS: This study analyzed data from...

Cite
Pasquali S, Palmerini E, Quagliuolo V, et al. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. Cancer. 2021;128(1):85-93doi: 10.1002/cncr.33895.
Pasquali, S., Palmerini, E., Quagliuolo, V., Martin-Broto, J., Lopez-Pousa, A., Grignani, G., Brunello, A., Blay, J. Y., Tendero, O., Diaz-Beveridge, R., Ferraresi, V., Lugowska, I., Infante, G., Braglia, L., Merlo, D. F., Fontana, V., Marchesi, E., Donati, D. M., Palassini, E., Bianchi, G., Marrari, A., Morosi, C., Stacchiotti, S., Bagué, S., Coindre, J. M., Dei Tos, A. P., Picci, P., Bruzzi, P., Miceli, R., Casali, P. G., & Gronchi, A. (2022). Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. Cancer, 128(1), 85-93. https://doi.org/10.1002/cncr.33895
Pasquali, Sandro, et al. "Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial." Cancer vol. 128,1 (2022): 85-93. doi: https://doi.org/10.1002/cncr.33895
Pasquali S, Palmerini E, Quagliuolo V, Martin-Broto J, Lopez-Pousa A, Grignani G, Brunello A, Blay JY, Tendero O, Diaz-Beveridge R, Ferraresi V, Lugowska I, Infante G, Braglia L, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Bianchi G, Marrari A, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Miceli R, Casali PG, Gronchi A. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. Cancer. 2022 Jan 01;128(1):85-93. doi: 10.1002/cncr.33895. Epub 2021 Oct 13. PMID: 34643947.
Copy Download .nbib Format: NLM
Measuring the impact of complications after surgery for retroperitoneal sarcoma: Is comprehensive complication index better than Clavien-Dindo Classification?.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Ruspi L, Cananzi FCM, Aymerito F, Sicoli F, Samà L, Vanni E, Quagliuolo V.
PMID: 34903429
Eur J Surg Oncol. 2021 Dec 08; doi: 10.1016/j.ejso.2021.12.010. Epub 2021 Dec 08.

BACKGROUND: To compare the Clavien-Dindo classification (CDC) and the Comprehensive Complication Index (CCI) in retroperitoneal sarcoma (RPS) surgery in assessing the real burden of post-operative complications on both post-operative length of stay and total costs of hospitalization (PLOS and...

Cite
Ruspi L, Cananzi FCM, Aymerito F, et al. Measuring the impact of complications after surgery for retroperitoneal sarcoma: Is comprehensive complication index better than Clavien-Dindo Classification?. Eur J Surg Oncol. 2021;doi: 10.1016/j.ejso.2021.12.010.
Ruspi, L., Cananzi, F. C. M., Aymerito, F., Sicoli, F., Samà, L., Vanni, E., & Quagliuolo, V. (2021). Measuring the impact of complications after surgery for retroperitoneal sarcoma: Is comprehensive complication index better than Clavien-Dindo Classification?. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, . https://doi.org/10.1016/j.ejso.2021.12.010
Ruspi, Laura, et al. "Measuring the impact of complications after surgery for retroperitoneal sarcoma: Is comprehensive complication index better than Clavien-Dindo Classification?." European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology vol. (2021). doi: https://doi.org/10.1016/j.ejso.2021.12.010
Ruspi L, Cananzi FCM, Aymerito F, Sicoli F, Samà L, Vanni E, Quagliuolo V. Measuring the impact of complications after surgery for retroperitoneal sarcoma: Is comprehensive complication index better than Clavien-Dindo Classification?. Eur J Surg Oncol. 2021 Dec 08; doi: 10.1016/j.ejso.2021.12.010. Epub 2021 Dec 08. PMID: 34903429.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 21 entries